We searched the proteins for domains with this function, and after excluding ones with roles that are not directly implicated in pathogenesis (e.g. signal peptidase, SOS response for DNA repair), we list the matches in Table 6.
Two cases were excluded: one with history of vaginal cancer and the other with endometrial cancer.
In the clinical sample, data from 22 individuals with ADHD were used, 2 from the 24 patients had to be excluded (one with autism spectrum disorder; one with Raven IQ performance was below 80).
Of these, we included 19 useable surveys in the analysis (excluding one survey with over 70% of responses missing), with 13 from Big Ten universities and 6 from Ivy-League universities.
Excluding one study with the highest RR where confounding with arsenic was thought to have occurred gave a combined RR of 1.14 (95% CI=1.04 1.73); this has been used for the higher-exposed workers in the AF estimation.
Excluding one woman with current use and 32 women with never use of MHT who had distant metastases at diagnosis did not change the survival estimates (data not shown).
After excluding one patient with a previous history of intracerebral hemorrhage, one patient with previous cerebral infarction, two patients who used psueodephedrine, one patient who had a history of marijuana use, one patient who was postpartum, and one heavy smoker, 24 patients were eligible for study.
Excluding one patient with missing response data, 7 of 10 patients responded with very good partial response (VGPR) or better.
Frequency distribution of 63 ratios of enrolled male and female subjects, excluding one study with a male/female ratio of 4.21 [16] and two studies on only males [61, 66].
Changes in time of sleep or treatment were analyzed with paired t-tests for participants who completed the trial, excluding one participant with incomplete sleep log data.
